6 articles in Hematology & Oncology

Neonatal Thromboembolic Disease: Rising Recognition Against a Thin Evidence Base
PathophysiologyPharmacology

Neonatal Thromboembolic Disease: Rising Recognition Against a Thin Evidence Base

Blood clots are one of the lesser-known risks of newborn intensive care. They form most often around the thin plastic tubes, called central lines, that carry nutrition and medicine into a sick baby's bloodstream. Three recent medical reports examined how often these clots happen, how doctors find…

scientificclinicalfamily
Fetal Hemoglobin as a Modifiable Target in Retinopathy of Prematurity: The First Randomized Trial of Cord-Blood Red-Cell Transfusion
Randomized Clinical TrialPhysiology

Fetal Hemoglobin as a Modifiable Target in Retinopathy of Prematurity: The First Randomized Trial of Cord-Blood Red-Cell Transfusion

Very premature babies often need blood transfusions, and those transfusions usually use blood donated by adults. A trial in Italy asked a new question: what if the blood came instead from donated umbilical cords, which is naturally richer in the type of hemoglobin a baby is born with? In its first…

scientificclinicalfamily
Harm That Outlasts the NICU: Two-Year Outcomes of Liberal Versus Restrictive Platelet Transfusion in Preterm Infants
Randomized Clinical Trial

Harm That Outlasts the NICU: Two-Year Outcomes of Liberal Versus Restrictive Platelet Transfusion in Preterm Infants

A large international study followed premature babies who had low platelet counts and found that giving platelet transfusions more freely did not help them and actually caused harm that lasted into early childhood. Babies given transfusions at a more generous threshold were more likely to have died or to have a developmental problem by age two than babies given them only when their counts fell much lower. The clear lesson: for these infants, a more cautious, "wait-and-watch" approach is safer.

scientificclinicalfamily